Literature DB >> 31409916

Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism.

Kaoru Yamashita1, Satoshi Morimoto2, Yasufumi Seki1, Daisuke Watanabe1, Atsuhiro Ichihara1.   

Abstract

Primary aldosteronism is characterized by inappropriate overproduction of aldosterone by adrenal lesions and leads to hypertension. Excess aldosterone causes organ damage; therefore, finding a biomarker for organ damage risk is vital. The (pro)renin receptor regulates the tissue renin-angiotensin-aldosterone system. The blood soluble (pro)renin receptor concentration is a candidate biomarker that reflects the activity of the tissue renin-angiotensin-aldosterone system. This study investigated the relationships between serum soluble (pro)renin receptor concentrations and indices of organ damage in patients with primary aldosteronism. We examined plasma aldosterone and serum soluble (pro)renin receptor concentrations in patients with primary aldosteronism and evaluated the relationships between these values and organ damage indices, such as the cardio-ankle vascular index, urinary albumin excretion, estimated glomerular filtration rate, and high-sensitivity C-reactive protein levels. We enrolled 121 patients with primary aldosteronism (46 males, 54.9 ± 12.2 years of age). Serum soluble (pro)renin receptor concentrations were significantly positively correlated with the cardio-ankle vascular index, urinary albumin excretion, and high-sensitivity C-reactive protein levels and negatively associated with estimated glomerular filtration rates, independent of other factors. Plasma aldosterone concentrations showed no significant relationships with these indices. In patients with primary aldosteronism, serum soluble (pro)renin receptor concentrations, but not plasma aldosterone concentrations, showed significant associations with organ damage, suggesting that the serum soluble (pro)renin receptor level could be a high-risk biomarker of organ damage.

Entities:  

Keywords:  Arteriosclerosis; cardio-ankle vascular index; high-sensitivity C-reactive protein; tissue renin–angiotensin–aldosterone system; urinary albumin secretion

Mesh:

Substances:

Year:  2019        PMID: 31409916     DOI: 10.1038/s41440-019-0312-9

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  33 in total

1.  Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.

Authors:  Ryuji Okamoto; Masaya Taniguchi; Yuki Onishi; Naoto Kumagai; Junji Uraki; Naoki Fujimoto; Eitaro Fujii; Yutaka Yano; Toru Ogura; Masaaki Ito
Journal:  Hypertens Res       Date:  2018-11-06       Impact factor: 3.872

2.  Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules.

Authors:  J Ludwig; S Kerscher; U Brandt; K Pfeiffer; F Getlawi; D K Apps; H Schägger
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

3.  Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism.

Authors:  Shinji Kishimoto; Takeshi Matsumoto; Kenji Oki; Tatsuya Maruhashi; Masato Kajikawa; Shogo Matsui; Haruki Hashimoto; Yasuki Kihara; Farina Mohamad Yusoff; Yukihito Higashi
Journal:  Hypertens Res       Date:  2018-09-11       Impact factor: 3.872

4.  Observational study mortality in treated primary aldosteronism: the German Conn's registry.

Authors:  Martin Reincke; Evelyn Fischer; Sabine Gerum; Katrin Merkle; Sebastian Schulz; Anna Pallauf; Marcus Quinkler; Gregor Hanslik; Katharina Lang; Stefanie Hahner; Bruno Allolio; Christa Meisinger; Rolf Holle; Felix Beuschlein; Martin Bidlingmaier; Stephan Endres
Journal:  Hypertension       Date:  2012-07-23       Impact factor: 10.190

5.  Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.

Authors:  Youichi Ohno; Masakatsu Sone; Nobuya Inagaki; Toshinari Yamasaki; Osamu Ogawa; Yoshiyu Takeda; Isao Kurihara; Hiroshi Itoh; Hironobu Umakoshi; Mika Tsuiki; Takamasa Ichijo; Takuyuki Katabami; Yasushi Tanaka; Norio Wada; Yui Shibayama; Takanobu Yoshimoto; Yoshihiro Ogawa; Junji Kawashima; Katsutoshi Takahashi; Megumi Fujita; Minemori Watanabe; Yuichi Matsuda; Hiroki Kobayashi; Hirotaka Shibata; Kohei Kamemura; Michio Otsuki; Yuichi Fujii; Koichi Yamamoto; Atsushi Ogo; Shintaro Okamura; Shozo Miyauchi; Tomikazu Fukuoka; Shoichiro Izawa; Takashi Yoneda; Shigeatsu Hashimoto; Toshihiko Yanase; Tomoko Suzuki; Takashi Kawamura; Yasuharu Tabara; Fumihiko Matsuda; Mitsuhide Naruse
Journal:  Hypertension       Date:  2018-01-22       Impact factor: 10.190

6.  Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice.

Authors:  Silvia Monticone; Jacopo Burrello; Davide Tizzani; Chiara Bertello; Andrea Viola; Fabrizio Buffolo; Luisa Gabetti; Giulio Mengozzi; Tracy A Williams; Franco Rabbia; Franco Veglio; Paolo Mulatero
Journal:  J Am Coll Cardiol       Date:  2017-04-11       Impact factor: 24.094

7.  Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats.

Authors:  Akira Nishiyama; Li Yao; Yukiko Nagai; Kayoko Miyata; Masanori Yoshizumi; Shoji Kagami; Shuji Kondo; Hideyasu Kiyomoto; Takatomi Shokoji; Shoji Kimura; Masakazu Kohno; Youichi Abe
Journal:  Hypertension       Date:  2004-02-09       Impact factor: 10.190

8.  Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.

Authors:  Sébastien Savard; Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

Review 9.  The biology of the (pro)renin receptor.

Authors:  Genevieve Nguyen; Dominik N Muller
Journal:  J Am Soc Nephrol       Date:  2009-11-16       Impact factor: 10.121

10.  Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.

Authors:  E Born-Frontsberg; M Reincke; L C Rump; S Hahner; S Diederich; R Lorenz; B Allolio; J Seufert; C Schirpenbach; F Beuschlein; M Bidlingmaier; S Endres; M Quinkler
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

View more
  2 in total

1.  (Pro)renin receptor antagonist PRO20 attenuates nephrectomy-induced nephropathy in rats via inhibition of intrarenal RAS and Wnt/β-catenin signaling.

Authors:  Yan Wang; Yurong Wang; Kai Xue; Huaijie Wang; Jingjing Zhou; Feng Gao; Chengde Li; Tianxin Yang; Hui Fang
Journal:  Physiol Rep       Date:  2021-06

2.  Circulating prorenin: its molecular forms and plasma concentrations.

Authors:  Kazumi Fujimoto; Sayuki Kawamura; Satoru Bando; Yuji Kamata; Yoshio Kodera; Masayoshi Shichiri
Journal:  Hypertens Res       Date:  2021-02-10       Impact factor: 3.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.